相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Clinical applications of attenuated MVA poxvirus strain
Carmen Elena Gomez et al.
EXPERT REVIEW OF VACCINES (2013)
Lethal Crimean-Congo Hemorrhagic Fever Virus Infection in Interferon α/β Receptor Knockout Mice Is Associated With High Viral Loads, Proinflammatory Responses, and Coagulopathy
Marko Zivcec et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
Timothy J. Powell et al.
PLOS ONE (2013)
Recombinant MVA vaccines: dispelling the myths
Matthew G. Cottingham et al.
VACCINE (2013)
Utilizing poxviral vectored vaccines for antibody induction-Progress and prospects
Simon J. Draper et al.
VACCINE (2013)
Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions
Baris Ozturk et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Development of an indirect ELISA method for the parallel measurement of IgG and IgM antibodies against Crimean-Congo haemorrhagic fever (CCHF) virus using recombinant nucleoprotein as antigen
S. D. Dowall et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine
Mehrdad Mousavi-Jazi et al.
VACCINE (2012)
Review of Crimean Congo Hemorrhagic Fever Infection in Kosova in 2008 and 2009: Prolonged Viremias and Virus Detected in Urine by PCR
Sherine Thomas et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2012)
Development of a Real-Time RT-PCR Assay for the Detection of Crimean-Congo Hemorrhagic Fever Virus
Barry Atkinson et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2012)
Therapeutic vaccination to treat chronic infectious diseases Current clinical developments using MVA-based vaccines
Houda Boukhebza et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor
Xiaodong Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Mice Orally Immunized with a Transgenic Plant Expressing the Glycoprotein of Crimean-Congo Hemorrhagic Fever Virus
S. M. Ghiasi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Complementation of Rickettsia rickettsii RelA/SpoT Restores a Nonlytic Plaque Phenotype
Tina R. Clark et al.
INFECTION AND IMMUNITY (2011)
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
Felipe Garcia et al.
VACCINE (2011)
Interacting Roles of Immune Mechanisms and Viral Load in the Pathogenesis of Crimean-Congo Hemorrhagic Fever
Ana Saksida et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Robert J. Amato et al.
CLINICAL CANCER RESEARCH (2010)
Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice
Sandor Bereczky et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model
Dennis A. Bente et al.
JOURNAL OF VIROLOGY (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass
Robert Alcock et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines
Zhongde Wang et al.
VACCINE (2010)
Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever
Esraguel Akinci et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
Lymphocyte subgroups in children with CCHF: A marker for prognosis
Hasan Tezer et al.
JOURNAL OF INFECTION (2009)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
Tony Hawkridge et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice
Mengcheng Luo et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity
Eric Bergeron et al.
JOURNAL OF VIROLOGY (2007)
Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara
Christine Meisinger-Henschel et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Viral load as predictor of crimean-congo hemorrhagic fever outcome
Darja Duh et al.
EMERGING INFECTIOUS DISEASES (2007)
Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein
Louis A. Altamura et al.
JOURNAL OF VIROLOGY (2007)
N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport
Bobbie R. Erickson et al.
VIROLOGY (2007)
Gateway (R) recombinational cloning: a biological operating system
Federico Katzen
EXPERT OPINION ON DRUG DISCOVERY (2007)
Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge
Julia Vipond et al.
VACCINE (2006)
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus
Kristin Spik et al.
VACCINE (2006)
Crimean-Congo haemorrhagic fever
Ö Ergönül
LANCET INFECTIOUS DISEASES (2006)
Evaluation of a Crimean-Congo hemorrhagic fever virus recombinant antigen expressed by Semliki Forest suicide virus for IgM and IgG antibody detection in human and animal sera collected in Iran
S Garcia et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein
AJ Sanchez et al.
JOURNAL OF VIROLOGY (2006)
Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus
AA Ahmed et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins
A Bertolotti-Ciarlet et al.
JOURNAL OF VIROLOGY (2005)
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
Sebastian Haferkamp et al.
VIROLOGY JOURNAL (2005)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Crimiean-Congo hemorrhagic fever, Mauritania
P Nabeth et al.
EMERGING INFECTIOUS DISEASES (2004)
Modified vaccinia ankara: Potential as an alternative smallpox vaccine
LH McCurdy et al.
CLINICAL INFECTIOUS DISEASES (2004)
Experimental infection of white-tailed deer (Odocoileus virginianus) with Ehrlichia chaffeensis by different inoculation routes
AS Varela et al.
JOURNAL OF WILDLIFE DISEASES (2003)
Crimean-congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1
MJ Vincent et al.
JOURNAL OF VIROLOGY (2003)
Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus
AJ Sanchez et al.
JOURNAL OF VIROLOGY (2002)
A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay
TW Tobery et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
分享论文
